Sub-$1 Watch: 10 Stocks That Could Explode — August 25, 2026

Overview As the market landscape evolves, stocks priced under $1 often present unique opportunities for traders willing to embrace high risk for potentially high rewards. Below, we analyze ten specific stocks currently trading under the $1 mark, emphasizing their volume trends, short interest, potential catalysts, and technical setups.

1. SNDL - Sundial Growers Inc. - **Current Price**: $0.33 - **Sector**: Cannabis - **Volume Profile**: Increasing, indicating investor interest. - **Short Interest**: 15%, suggesting potential for a short squeeze. - **Catalyst**: Potential legalization of cannabis in key markets. - **Technical Setup**: Recently bounced off support at $0.30. - **Risk Factors**: Regulatory hurdles could impede growth. - **Bull Case Price Target**: $0.50 (30-90 days). - **Risk Rating**: 🔴 Very High

2. MVIS - MicroVision, Inc. - **Current Price**: $0.89 - **Sector**: Technology - **Volume Profile**: Significant accumulation over the past month. - **Short Interest**: 20%, indicating a possible squeeze. - **Catalyst**: Upcoming product demonstrations in augmented reality. - **Technical Setup**: Breaking out of a multi-week consolidation zone. - **Risk Factors**: Competition in the AR space could limit market share. - **Bull Case Price Target**: $1.20 (30-90 days). - **Risk Rating**: 🟡 High

3. CLOV - Clover Health Investments Corp. - **Current Price**: $0.70 - **Sector**: Health Insurance - **Volume Profile**: Increasing volume, signaling accumulation. - **Short Interest**: 25%, high potential for a short squeeze. - **Catalyst**: Release of quarterly earnings, expected to show improved metrics. - **Technical Setup**: Recently found support near $0.65. - **Risk Factors**: Regulatory scrutiny in the healthcare sector. - **Bull Case Price Target**: $1.00 (30-90 days). - **Risk Rating**: 🟡 High

4. AITX - Artificial Intelligence Technology Solutions, Inc. - **Current Price**: $0.12 - **Sector**: Technology - **Volume Profile**: Surge in volume indicates growing investor interest. - **Short Interest**: 10%, manageable short interest. - **Catalyst**: New contract announcements for AI solutions. - **Technical Setup**: Bouncing off of a long-term support level. - **Risk Factors**: High dependency on new contracts for revenue. - **Bull Case Price Target**: $0.20 (30-90 days). - **Risk Rating**: 🟢 Moderate

5. ZOM - Zomedica Corp. - **Current Price**: $0.37 - **Sector**: Veterinary Diagnostics - **Volume Profile**: Steady accumulation observed. - **Short Interest**: 12%, indicating limited downside risk. - **Catalyst**: Launch of new veterinary products. - **Technical Setup**: Recently broke above a key resistance level. - **Risk Factors**: Limited market size in the veterinary field. - **Bull Case Price Target**: $0.50 (30-90 days). - **Risk Rating**: 🟡 High

6. GME - GameStop Corp. (Warrants) - **Current Price**: $0.95 - **Sector**: Retail - **Volume Profile**: Increased trading volume suggests renewed interest. - **Short Interest**: 30%, significant potential for a squeeze. - **Catalyst**: Potential pivot to digital sales strategy. - **Technical Setup**: Testing a critical breakout level. - **Risk Factors**: Market volatility could impact retail sector. - **Bull Case Price Target**: $1.50 (30-90 days). - **Risk Rating**: 🔴 Very High

7. CYN - CYNOSURE, INC. - **Current Price**: $0.45 - **Sector**: Medical Devices - **Volume Profile**: Volume has been steadily increasing. - **Short Interest**: 18%, indicating potential for short covering. - **Catalyst**: FDA approval for a new device. - **Technical Setup**: Approaching a breakout point at $0.50. - **Risk Factors**: FDA delays could harm stock performance. - **Bull Case Price Target**: $0.70 (30-90 days). - **Risk Rating**: 🟡 High

8. HCMC - Healthier Choices Management Corp. - **Current Price**: $0.01 - **Sector**: Health & Wellness - **Volume Profile**: Recent spike in volume. - **Short Interest**: 5%, minimal short interest. - **Catalyst**: Legal proceedings in progress that could favor the company. - **Technical Setup**: Trading in a tight range; potential breakout imminent. - **Risk Factors**: Legal outcomes are uncertain. - **Bull Case Price Target**: $0.03 (30-90 days). - **Risk Rating**: 🔴 Very High

9. CBAI - CBA Florida, Inc. - **Current Price**: $0.25 - **Sector**: Financial Services - **Volume Profile**: Notable increase in trading volume. - **Short Interest**: 8%, low risk for short squeezes. - **Catalyst**: New financial product launch. - **Technical Setup**: Recently bounced off support at $0.20. - **Risk Factors**: Market competition is fierce in finance. - **Bull Case Price Target**: $0.40 (30-90 days). - **Risk Rating**: 🟢 Moderate

10. ADMP - Adamis Pharmaceuticals Corporation - **Current Price**: $0.54 - **Sector**: Pharmaceuticals - **Volume Profile**: Increasing volume in anticipation of news. - **Short Interest**: 22%, indicating potential for a squeeze. - **Catalyst**: Anticipated FDA decision on a new drug. - **Technical Setup**: Testing key resistance at $0.60. - **Risk Factors**: FDA rejections can dramatically impact stock price. - **Bull Case Price Target**: $0.80 (30-90 days). - **Risk Rating**: 🟡 High

Why These Price Ranges Matter Low-priced stocks often have low floats, meaning that even small buying interest can lead to significant price movements. The mechanical advantages of low-float, low-price stocks make them attractive for traders looking to capitalize on volatility. Additionally, the potential for short squeezes is heightened in this price range due to low market capitalization.

How to Trade Them Safely When trading sub-$1 stocks, position sizing is critical. Allocate only a small portion of your portfolio to these high-risk equities. Use limit orders to control entry points, and always set stop-loss orders to mitigate potential losses. Timing catalysts, such as earnings reports or FDA approvals, can enhance the likelihood of favorable price movements.

Catalyst Calendar - **SNDL**: Cannabis legalization vote on September 15, 2026. - **MVIS**: Product demo on September 10, 2026. - **CLOV**: Earnings report on October 5, 2026. - **ADMP**: FDA decision on new drug scheduled for October 15, 2026.

These stocks represent high-risk speculative plays. Maintain strict risk management practices as you navigate these volatile markets.

Educational content only. Not financial advice. DYOR.